About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Candesartan Cilexetil
- Company
- Baylor Research Institute
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 9 recruiting
Efficacy results: Not yet reported
9 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026
Find a Clinical Trial Near Me
See recruiting studies for Candesartan Cilexetil and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02735707
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sitesOther conditions: Community-acquired Pneumonia, Influenza, COVID-19View official trial listing → -
Recruiting NCT NCT02817360
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sitesType 2 diabetes Other conditions: Heart DiseasesView official trial listing → -
Recruiting NCT NCT03460327
Bariatric Surgery and Pharmacokinetics of Candesartan
Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 siteOther conditions: Obesity, MorbidView official trial listing → -
Recruiting NCT NCT03770702
Statins and ARBs on Rheumatoid Activity
Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2026-12-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT03770936
Effect of Some Drugs on Liver Fibrosis
Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2027-11 1 siteOther conditions: Liver FibrosesView official trial listing → -
Recruiting NCT NCT05321875
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Not yet reported Cristina Avendaño Solá 320 participants Est. completion 2026-06-02 1 siteOther conditions: Cardiomyopathy, DilatedView official trial listing → -
Recruiting NCT NCT05498675
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 siteOther conditions: Sacubitril/Valsartan, Hypertension, ObesityView official trial listing → -
Recruiting NCT NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2025-12-30 1 siteCardiovascular disease Other conditions: Hypertension, Essential, CardiologyView official trial listing → -
Recruiting NCT NCT07513883
The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.
Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 siteHeart failureView official trial listing → -
Completed NCT NCT00000620
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sitesCardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary DiseaseView official trial listing → -
Completed NCT NCT00005520
Genetic Epidemiology of Responses to Antihypertensives
Mayo Clinic 1200 participants Est. completion 2008-01 1 siteCardiovascular disease Other conditions: Heart Diseases, HypertensionView official trial listing → -
Completed NCT NCT00081731
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 siteCardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery ObstructionView official trial listing → -
Status unknown NCT NCT00108706
Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
Not yet reported City Hospitals Sunderland NHS Foundation Trust 50 participants Est. completion 2007-09 1 siteCardiovascular disease Other conditions: Cerebrovascular AccidentView official trial listing → -
Completed NCT NCT00120003
Scandinavian Candesartan Acute Stroke Trial (SCAST)
Not yet reported Ullevaal University Hospital 2500 participants Est. completion 2010-09 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT00125463
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
Not yet reported The Japanese Society of Hypertension 3200 participants Est. completion 2005-12 1 siteCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00130975
Candesartan in the Prevention of Relapsing Atrial Fibrillation
Not yet reported Asker & Baerum Hospital 200 participants Est. completion 2005-09 2 sitesOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT00139386
Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
Not yet reported Kumamoto University 1119 participants Est. completion 2012-04 1 siteCardiovascular disease Other conditions: HypertensionView official trial listing → -
Terminated NCT NCT00141583
The Renin-Angiotensin System in Essential Hypertension
Not yet reported St George's, University of London 11 participants Est. completion 2006-10 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00150631
Danish Hypertension Prevention Project - DHYPP
Not yet reported Karin Skov 100 participants Est. completion 2014-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00154037
Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
Not yet reported Technische Universität Dresden 40 participants Est. completion 2006-09 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00154050
High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty
Not yet reported Technische Universität Dresden 22 participants Est. completion 2006-07 1 siteOther conditions: Arterial Occlusive DiseasesView official trial listing → -
Completed NCT NCT00184587
Prophylactic Treatment of Episodic Cluster Headache
Not yet reported Norwegian University of Science and Technology 40 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Cluster HeadacheView official trial listing → -
Status unknown NCT NCT00192803
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs
Not yet reported Rambam Health Care Campus 20 participants 1 siteOther conditions: NIDDMView official trial listing → -
Completed NCT NCT00227318
TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
Not yet reported AstraZeneca 1000 participants Est. completion 2005-10 42 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00231803
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT00232882
Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
Not yet reported Institut de Recherches Cliniques de Montreal 86 participants Est. completion 2006-04 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00235287
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
Not yet reported Herlev Hospital 60 participants 1 siteCardiovascular disease Other conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT00242346
High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
Not yet reported AstraZeneca 270 participants Est. completion 2006-12 26 sitesOther conditions: ProteinuriaView official trial listing → -
Completed NCT NCT00244595
Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age
Not yet reported AstraZeneca 235 participants Est. completion 2006-11 44 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00244621
Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
Not yet reported AstraZeneca 95 participants Est. completion 2008-08 38 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00244634
Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
Not yet reported AstraZeneca 238 participants Est. completion 2005-11 44 sitesOther conditions: Pediatric HypertensionView official trial listing → -
Completed NCT NCT00252694
DIabetic Retinopathy Candesartan Trials
Not yet reported AstraZeneca 4717 participants Est. completion 2008-04 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00252720
DIabetic Retinopathy Candesartan Trials.
Not yet reported AstraZeneca 1850 participants Est. completion 2008-04 Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00252733
Diabetic Retinopathy Candesartan Trials
Not yet reported AstraZeneca 5238 participants Est. completion 2008-04 3 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00282178
Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
Not yet reported Umeå University 26 participants Est. completion 2006-04 1 siteOther conditions: Hypertension, ObesityView official trial listing → -
Status unknown NCT NCT00288717
Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients
Not yet reported Saitama Medical University 300 participants Est. completion 2007-09 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00294775
Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
Not yet reported Odense University Hospital 140 participants Est. completion 2009-06 1 siteOther conditions: Aortic Valve Stenosis, Left Ventricular Hypertrophy, Atrial FibrillationView official trial listing → -
Completed NCT NCT00310778
Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2007-03 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00319202
Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects
Not yet reported Fundación Cardiovascular de Colombia 56 participants Est. completion 2012-02 1 siteOther conditions: Glucose Intolerance, ObesityView official trial listing → -
Completed NCT NCT00320970
Angiotensin II Antagonism of TGF-Beta 1
Not yet reported Providence Health & Services 36 participants Est. completion 2004-09 1 siteChronic kidney disease Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00328302
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
Not yet reported Karolinska University Hospital 13 participants Est. completion 2006-04 1 siteOther conditions: Diabetes, Type IView official trial listing → -
Completed NCT NCT00348686
Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
Not yet reported AstraZeneca 315 participants Est. completion 2008-06 11 sitesOther conditions: Hypertension, Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT00356395
Safety and Effects of Ramipril Combined With Candesartan
Not yet reported Gachon University Gil Medical Center 40 participants Est. completion 2006-03Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00360178
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
Not yet reported Novartis 198 participants Est. completion 2006-12 2 sitesOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00360763
Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
Not yet reported Huazhong University of Science and Technology 600 participants Est. completion 2006-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00383929
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Not yet reported AstraZeneca 1979 participants Est. completion 2007-10 132 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00391846
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sitesHeart failure Other conditions: Ventricular Dysfunction, LeftView official trial listing → -
Completed NCT NCT00400582
A Pharmacogenomic Study of Candesartan in Heart Failure
Not yet reported Montreal Heart Institute 300 participants Est. completion 2010-04 1 siteHeart failureView official trial listing → -
Status unknown NCT NCT00430833
CHANCE - Candesartan in Hypertrophic Cardiomyopathy
Not yet reported Charles University, Czech Republic 1 siteOther conditions: Hypertrophic CardiomyopathyView official trial listing → -
Completed NCT NCT00434967
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Not yet reported AstraZeneca 2207 participants Est. completion 2008-01 27 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00459771
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
Not yet reported The Netherlands Cancer Institute 210 participants Est. completion 2014-12 19 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00468923
Heart Outcomes Prevention Evaluation-3
Not yet reported Population Health Research Institute 12705 participants Est. completion 2016-01 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00512759
Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study
Not yet reported University Hospital, Basel, Switzerland 781 participants Est. completion 2019-02-21 12 sites Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT00526279
COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus
AstraZeneca 9000 participants Est. completion 2008-08 3 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00530595
Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients
Not yet reported Saitama Medical UniversityCardiovascular diseaseView official trial listing → -
Completed NCT NCT00538486
A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Not yet reported Third Military Medical University 360 participants Est. completion 2009-06 1 siteOther conditions: Hypertension, ObesityView official trial listing → -
Status unknown NCT NCT00541853
CCB Safety Study in Treatment of Hypertension of ADPKD
Not yet reported Kyorin University 150 participants Est. completion 2012-11 6 sitesOther conditions: Kidney, Polycystic, Autosomal DominantView official trial listing → -
Status unknown NCT NCT00564057
Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
Not yet reported Università degli Studi dell'Insubria 30 participants Est. completion 2009-09 1 siteOther conditions: HIV Infections, HypertensionView official trial listing → -
Completed NCT NCT00573430
ARIA (Atacand Renoprotection In NephropAthy Pt.)
Not yet reported AstraZeneca 128 participants Est. completion 2009-08 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT00573742
Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
AstraZeneca 1940 participants Est. completion 2008-02 16 sitesOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT00587470
Angiotensin-II Blockade in Mitral Regurgitation
Not yet reported Mayo Clinic 60 participants Est. completion 2001-08 1 site Stand-aloneOther conditions: Mitral RegurgitationView official trial listing → -
Completed NCT NCT00605072
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
Not yet reported University of Southern California 53 participants Est. completion 2012-12 2 sitesOther conditions: Cognitive Impairment, Hypertension, AgingView official trial listing → -
Completed NCT NCT00607633
Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
AstraZeneca 686 participants Est. completion 2007-10Other conditions: Essential Hypertension, Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT00607672
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Not yet reported Vanderbilt University 111 participants Est. completion 2011-12 2 sitesCardiovascular disease Other conditions: Angiotensin Converting Enzyme, Angiotensin Receptor Blockers, Cardiopulmonary Bypass, Fibrinolysis, InflammationView official trial listing → -
Completed NCT NCT00608153
Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
AstraZeneca 1773 participants Est. completion 2007-09Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00620178
Atacand (Candesartan) Real Life Study
AstraZeneca 14000 participants Est. completion 2009-02 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00621153
Candesartan Effect in Second Stage Arterial Hypertension
Not yet reported AstraZeneca 214 participants Est. completion 2009-03 1 site Stand-aloneOther conditions: Stage II HypertensionView official trial listing → -
Completed NCT NCT00634309
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)
Not yet reported AstraZeneca 597 participants Est. completion 2003-05Heart failureView official trial listing → -
Completed NCT NCT00634400
Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)
Not yet reported AstraZeneca 6268 participants Est. completion 2003-05Heart failureView official trial listing → -
Completed NCT NCT00634712
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
Not yet reported AstraZeneca 734 participants Est. completion 2003-05Heart failureView official trial listing → -
Status unknown NCT NCT00644475
Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
Not yet reported University of Pavia 60 participants Est. completion 2009-03 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00670787
Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 siteOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00679484
Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24
Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 400 participants Est. completion 2009-11 11 sites Stand-aloneHeart failure Other conditions: High Blood B-type (or Brain) Natriuretic Peptide (BNP) LevelView official trial listing → -
Completed NCT NCT00679640
Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
AstraZeneca 450 participants Est. completion 2010-07 103 sitesHeart failure Other conditions: Cohort StudyView official trial listing → -
Completed NCT NCT00684489
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00690612
Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
Not yet reported AstraZeneca 35 participants Est. completion 2009-09 13 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00699452
The Potential of Candesartan to Retard the Progression of Aortic Stenosis
Not yet reported University of Helsinki 120 participants Est. completion 2014-12 1 siteOther conditions: Aortic Valve StenosisView official trial listing → -
Completed NCT NCT00741585
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sitesCardiovascular diseaseChronic kidney disease Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00775814
Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
Not yet reported Takeda 188 participants Est. completion 2008-09 24 sitesOther conditions: Obesity, HypertensionView official trial listing → -
Completed NCT NCT00775840
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
Not yet reported Takeda 22 participants Est. completion 2008-12 37 sitesHeart failureView official trial listing → -
Completed NCT NCT00802542
In-practice Evaluation of Atacand 16mg Antihypertensive Effect
AstraZeneca 400 participants Est. completion 2009-01 4 sitesOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00837720
Evaluation of Atacand® (Candesartan) in Daily Medical Practice
AstraZeneca 750 participants Est. completion 2007-06Other conditions: HypertensionView official trial listing → -
Terminated NCT NCT00843154
Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
Not yet reported Takeda 571 participants Est. completion 2008-07Heart failureView official trial listing → -
Completed NCT NCT00844324
Bioequivalence Study in Healthy Subjects
Not yet reported AstraZeneca 36 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00863980
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
Not yet reported Kyoto Prefectural University of Medicine 1500 participants Est. completion 2013-07 32 sitesCardiovascular disease Other conditions: Angina Pectoris, Myocardial Ischemia, Acute Coronary Syndrome, HypertensionView official trial listing → -
Completed NCT NCT00867490
Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
Not yet reported Novartis 186 participants Est. completion 2009-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00884663
Candesartan Versus Propranolol for Migraine Prevention
Not yet reported, Not yet reported Norwegian University of Science and Technology 72 participants Est. completion 2012-03 1 siteOther conditions: Migraine Without Aura, Migraine With Aura, Chronic MigraineView official trial listing → -
Status unknown NCT NCT00890279
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Not yet reported Ministry of Health, Labour and Welfare, Japan 160 participants Est. completion 2012-11 9 sitesOther conditions: Kidney, Polycystic, Autosomal DominantView official trial listing → -
Completed NCT NCT00905333
Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal
Not yet reported AstraZeneca 36 participants Est. completion 2008-11 2 sitesOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT00930995
Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C
Not yet reported Kaiser Permanente 2 sitesOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00984529
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
AstraZeneca 500 participants Est. completion 2010-02 15 sitesHeart failureView official trial listing → -
Completed NCT NCT00990639
Effect of Candesartan in Alcoholic Liver Fibrosis
Not yet reported, Not yet reported Yonsei University 85 participants Est. completion 2009-03 1 siteOther conditions: Alcoholic Liver DiseaseView official trial listing → -
Completed NCT NCT01012479
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
Not yet reported Takeda 107 participants Est. completion 2010-06 16 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01025843
Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)
Not yet reported Merck Sharp & Dohme LLC 20 participants Est. completion 2010-05-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01052272
Impact of Diabetes on Left Ventricular Remodeling
Not yet reported, Not yet reported University of Alabama at Birmingham 72 participants Est. completion 2010-11 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01062451
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Not yet reported Baylor College of Medicine 80 participants Est. completion 2013-11-20 1 siteOther conditions: Methamphetamine Dependence, Methamphetamine Abuse, Substance AbuseView official trial listing → -
Completed NCT NCT01116180
Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System
Not yet reported Louise Faerch 9 participants Est. completion 2013-02 1 siteOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Completed NCT NCT01135212
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
Not yet reported Boryung Pharmaceutical Co., Ltd 290 participants Est. completion 2011-05 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01152567
Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
AstraZeneca 50000 participants Est. completion 2010-11 56 sitesCardiovascular disease Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01162902
Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation
Not yet reported Seoul National University Hospital 150 participants Est. completion 2015-12 1 siteOther conditions: Stable AnginaView official trial listing → -
Status unknown NCT NCT01198496
Recurrent Stroke Prevention Clinical Outcome Study
Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 siteCardiovascular disease Other conditions: Hypertension, Blood PressureView official trial listing → -
Completed NCT NCT01227603
Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions
Not yet reported Bayer 49 participants Est. completion 2011-07 1 siteOther conditions: Hypertension, EssentialView official trial listing → -
Status unknown NCT NCT01273675
An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
National Taiwan University Hospital 100 participantsChronic kidney diseaseView official trial listing → -
Completed NCT NCT01289132
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
Not yet reported Takeda 926 participants Est. completion 2008-07Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01303783
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
Not yet reported Bayer 1381 participants Est. completion 2012-05 157 sites Stand-aloneOther conditions: Hypertension, EssentialView official trial listing → -
Completed NCT NCT01350609
Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed
Not yet reported Bayer 49 participants Est. completion 2011-09 1 siteOther conditions: Hypertension, EssentialView official trial listing → -
Status unknown NCT NCT01377285
Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 siteOther conditions: Chronic Renal FailureView official trial listing → -
Completed NCT NCT01434134
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
Not yet reported University Hospital, Akershus 130 participants Est. completion 2014-09 1 siteHeart failure Other conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01444833
Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker
Not yet reported Slovak Academy of Sciences 35 participants Est. completion 2012-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01611077
Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
Not yet reported Institut für Pharmakologie und Präventive Medizin 88 participants Est. completion 2013-01 11 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01613209
Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
Not yet reported Institut für Pharmakologie und Präventive Medizin 83 participants Est. completion 2012-10 12 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01629225
GRK4 Polymorphisms Blood Pressure Response to Candesartan
Not yet reported Third Military Medical University 500 participants Est. completion 2015-07 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01678794
CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
Not yet reported, Not yet reported Mayo Clinic 33 participants Est. completion 2016-06-29 1 siteOther conditions: Cardiorenal Syndrome (CRS)View official trial listing → -
Completed NCT NCT01682564
To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
Not yet reported Chong Kun Dang Pharmaceutical 169 participants Est. completion 2014-10 14 sitesHeart failure Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01715584
Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01734096
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
Not yet reported PD Dr. Grégoire Wuerzner 78 participants Est. completion 2016-04 2 sitesOther conditions: Hypertension, Obesity, White Coat Hypertension, Resistant HypertensionView official trial listing → -
Terminated NCT NCT01766505
The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-03 9 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01788358
Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
Not yet reported Bayer 508 participants Est. completion 2014-05-01 82 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT01794455
Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
Not yet reported Vanderbilt University 1 participants Est. completion 2015-03 1 siteOther conditions: Depression, HypertensionView official trial listing → -
Completed NCT NCT01806311
Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
Not yet reported HanAll BioPharma Co., Ltd. 36 participants Est. completion 2013-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01827202
RAS Quantification in Patients With Aliskiren or Candesartan
Not yet reported Medical University of Vienna 24 participants Est. completion 2016-02 1 siteChronic kidney disease Other conditions: Hypertension, ProteinuriaView official trial listing → -
Status unknown NCT NCT01845272
Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate
Not yet reported HK inno.N Corporation 40 participants Est. completion 2013-08 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01926652
Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 34 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01938664
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
Not yet reported Baylor College of Medicine 30 participants Est. completion 2016-07 1 siteOther conditions: Cocaine DependenceView official trial listing → -
Completed NCT NCT01976572
Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
Not yet reported Tanabe Pharma Corporation 18 participants Est. completion 2014-01 1 siteChronic kidney disease Other conditions: HyperphosphatemiaView official trial listing → -
Completed NCT NCT01984164
CAndesartan vs LIsinopril Effects on the BRain
Not yet reported Emory University 176 participants Est. completion 2018-12-03 1 siteOther conditions: Hypertension, Mild Cognitive ImpairmentView official trial listing → -
Status unknown NCT NCT01992796
Angiotensin II Antagonist in Severe Sepsis
Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 siteOther conditions: Severe SepsisView official trial listing → -
Completed NCT NCT02006589
Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
Not yet reported GlaxoSmithKline 16 participants Est. completion 2014-01-22 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02006602
Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
Not yet reported GlaxoSmithKline 16 participants Est. completion 2014-01-22 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02016183
Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
Takeda 3222 participants Est. completion 2012-09-30 1 siteOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT02047019
Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
Not yet reported Bayer Est. completion 2019-12-08 8 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02059616
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
Not yet reported HK inno.N Corporation 384 participants Est. completion 2015-12 20 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02064556
CKD-330 Drug-Drug Interaction Study (Amlodipine)
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02064621
CKD-330 Drug-Drug Interaction Study (Candesartan)
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02068495
Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
Takeda 3409 participants Est. completion 2013-05-31Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02079506
Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin
Not yet reported Alvogen Korea 40 participants Est. completion 2014-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02094924
A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
Not yet reported GlaxoSmithKline 16 participants Est. completion 2014-05-23 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02166697
Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
Takeda 14151 participants Est. completion 2010-11Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02173912
Bioequivalence Study of CJ-30059
Not yet reported HK inno.N Corporation 32 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02186496
Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-11 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02200822
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients
Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 siteHeart failureView official trial listing → -
Status unknown NCT NCT02206165
A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
Not yet reported Chong Kun Dang Pharmaceutical 456 participants Est. completion 2015-06 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02211638
Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
Takeda 18113 participants Est. completion 2013-04-25 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02254447
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
Not yet reported GlaxoSmithKline 18 participants Est. completion 2015-01-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02261116
Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers
Not yet reported Boehringer Ingelheim 24 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02332824
A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
Not yet reported Takeda 415 participants Est. completion 2016-08-18 68 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02368652
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
Not yet reported HK inno.N Corporation 181 participants Est. completion 2015-11 19 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02368665
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
Not yet reported HK inno.N Corporation 180 participants Est. completion 2016-11 19 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Withdrawn NCT NCT02521233
Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
Not yet reported EMS Est. completion 2017-08 Stand-aloneOther conditions: Essential Arterial HypertensionView official trial listing → -
Withdrawn NCT NCT02521246
Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
Not yet reported EMS Est. completion 2017-08 Stand-aloneOther conditions: Essential Arterial HypertensionView official trial listing → -
Completed NCT NCT02548286
Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
Not yet reported Chong Kun Dang Pharmaceutical 53 participants Est. completion 2015-09 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02609711
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 90 participants 1 siteOther conditions: Healthy Male SubjectsView official trial listing → -
Status unknown NCT NCT02614352
Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 60 participantsOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT02646982
Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
Not yet reported Emory University 77 participants Est. completion 2020-08-17 2 sitesOther conditions: Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT02651870
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Not yet reported Chong Kun Dang Pharmaceutical 135 participants Est. completion 2016-02-29 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02707224
Clinical Trial to Compare the Pharmacokinetics of DP-R208
Not yet reported Alvogen Korea 40 participants Est. completion 2015-06 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02709187
DP-R208 Pharmacokinetic Study
Not yet reported Alvogen Korea 37 participants Est. completion 2016-05 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02770261
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
Not yet reported Alvogen Korea 219 participants Est. completion 2016-10 1 siteOther conditions: Hypertension, CholesterolemiaView official trial listing → -
Completed NCT NCT02774460
The Precision Hypertension Care Study
Not yet reported Uppsala University 280 participants Est. completion 2021-06-11 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02801526
Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02811731
Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02879721
Expression and Function of the Renin-Angiotensin System in the Esophagus
Not yet reported Göteborg University 33 participants Est. completion 2012-12 1 siteOther conditions: Barrett's EsophagusView official trial listing → -
Completed NCT NCT02944734
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 392 participants Est. completion 2015-12 23 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Withdrawn NCT NCT02969265
An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
Not yet reported Takeda Est. completion 2018-07-26 25 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02988362
Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Not yet reported HanAll BioPharma Co., Ltd. 42 participants Est. completion 2017-02-04Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03136666
Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.
Not yet reported Bayer 12 participants Est. completion 2010-06-07 1 site Stand-aloneOther conditions: Clinical PharmacologyView official trial listing → -
Status unknown NCT NCT03231982
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
Not yet reported HK inno.N Corporation 210 participants Est. completion 2019-05-31 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Active, not recruiting NCT NCT03583866
Adiposity and Endothelin Receptor Function
Not yet reported Augusta University 25 participants Est. completion 2026-01 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03640312
Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension
Not yet reported Washington University School of Medicine 62 participants Est. completion 2024-07-31 2 sitesOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT03688633
Candesartan in Peripheral Neuropathy
Not yet reported University Hospital, Limoges 9 participants Est. completion 2021-05-27 1 siteOther conditions: Peripheral NeuropathyView official trial listing → -
Completed NCT NCT03847506
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT04012307
The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions
Not yet reported Pharmtechnology LLC 40 participants Est. completion 2019-08-14 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04061824
Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04138316
CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study
Hospital Clínico Universitario de Valladolid 85 participants Est. completion 2022-12-16 1 siteOther conditions: Migraine, Head PainView official trial listing → -
Completed NCT NCT04245046
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-02-18 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04320589
the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma
Not yet reported National Cancer Institute, Egypt 30 participants Est. completion 2021-08-30 1 siteOther conditions: PheochromocytomaView official trial listing → -
Suspended NCT NCT04330300
Coronavirus (COVID-19) ACEi/ARB Investigation
Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 siteOther conditions: Hypertension, COVID-19View official trial listing → -
Status unknown NCT NCT04351724
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Not yet reported, Not yet reported Medical University of Vienna 500 participants Est. completion 2022-03-31 9 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04394117
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sitesOther conditions: Coronavirus Disease 2019, COVID-19View official trial listing → -
Status unknown NCT NCT04429633
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Not yet reported Samsung Medical Center 136 participants Est. completion 2023-07-18 1 siteOther conditions: Cardiotoxicity, Breast Cancer, Prevention, Adjuvant, TrastuzumabView official trial listing → -
Withdrawn NCT NCT04430959
Candesartan as an Adjunctive Treatment for Bipolar Depression
Not yet reported The University of Texas Health Science Center, Houston Est. completion 2022-09-01 1 siteOther conditions: Bipolar Disorder DepressionView official trial listing → -
Completed NCT NCT04467931
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
University of Utah 22213 participants Est. completion 2020-12-31 1 siteOther conditions: Hypertension, COVIDView official trial listing → -
Completed NCT NCT04521023
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Not yet reported Chong Kun Dang Pharmaceutical 132 participants Est. completion 2020-06-03 14 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04574713
Candesartan for Migraine Prevention:
Not yet reported St. Olavs Hospital 450 participants Est. completion 2024-08-08 10 sitesOther conditions: MigraineView official trial listing → -
Completed NCT NCT04591210
The COVID-RASi Trial (COVID-19)
Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sitesCardiovascular disease Other conditions: COVID-19View official trial listing → -
Terminated NCT NCT04606563
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sitesOther conditions: Covid19, SARS-CoV InfectionView official trial listing → -
Status unknown NCT NCT04743063
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 siteHeart failure Other conditions: FrailtyView official trial listing → -
Terminated NCT NCT05122182
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Not yet reported University of Sydney 49 participants Est. completion 2023-01-28 10 sites Stand-aloneOther conditions: COVID-19, SARS-CoV2 InfectionView official trial listing → -
Not yet recruiting NCT NCT05169021
Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD
Not yet reported Beijing Tiantan Hospital 15000 participants Est. completion 2028-12-31 1 siteCardiovascular disease Other conditions: Cerebral Small Vessel DiseasesView official trial listing → -
Status unknown NCT NCT05271448
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 siteChronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT05328635
Post-traumatic Headache Multidisciplinary Study
Danish Headache Center 58 participants Est. completion 2024-09-01 1 siteOther conditions: Post-Traumatic Headache, Post-Concussion SyndromeView official trial listing → -
Completed NCT NCT05535595
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
Not yet reported Yonsei University 77 participants Est. completion 2021-08-02 1 siteOther conditions: HypertensionView official trial listing → -
Active, not recruiting NCT NCT05637853
Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction
Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 siteHeart failureView official trial listing → -
Enrolling by invitation NCT NCT05826912
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Not yet reported University of California, San Francisco 672 participants Est. completion 2029-08-31 18 sitesOther conditions: Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT05920005
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension
Not yet reported Hospital Israelita Albert Einstein 702 participants Est. completion 2025-05-01 22 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT06212648
Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 253 participants Est. completion 2023-01-27 1 siteOther conditions: Hypertension, Essential HypertensionView official trial listing → -
Not yet recruiting NCT NCT06460896
Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs
Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2027-09 1 siteOther conditions: Bypass Bariatric SurgeryView official trial listing → -
Status unknown NCT NCT06515678
Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sitesOther conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, HypertensionView official trial listing → -
Enrolling by invitation NCT NCT06646354
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 siteOther conditions: Hypertension, Primary HypercholesterolaemiaView official trial listing → -
Completed NCT NCT06697353
An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
Bayer 4936 participants Est. completion 2025-09-19 1 siteHeart failureView official trial listing → -
Enrolling by invitation NCT NCT07064525
Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2026-02-28 1 siteHeart failure Other conditions: Hypertension (HTN), Diabete MellitusView official trial listing → -
Not yet recruiting NCT NCT07135245
Improved Treatment and Monitoring of Alzheimer's Disease
Not yet reported Rune Skovgaard Rasmussen 180 participants Est. completion 2031-09-30Other conditions: Alzheimer Disease (AD)View official trial listing → -
Not yet recruiting NCT NCT07262710
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19Cardiovascular diseaseView official trial listing → -
Enrolling by invitation NCT NCT07547878
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07655440
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Not yet reported Stanford University 120 participants Est. completion 2031-07Other conditions: Migraine Associated Vertigo, Tinnitus, Migraine, Vestibular MigraineView official trial listing → -
Not yet recruiting NCT NCT07687160
SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy
Not yet reported Ottawa Hospital Research Institute 30 participants Est. completion 2028-02 4 sitesOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT07735130
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
Not yet reported Seoul National University Hospital 632 participants Est. completion 2030-06-15 1 siteOther conditions: Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic StenosisView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Candesartan Cilexetil, ATACAND, ATACAND HCT
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.